Vermeire S, Hebuterne X, Tilg H, De Hertogh G, et al. Induction and long-term follow-up with ABX464 for moderate-to-severe ulcerative colitis: Results of phase 2a trial. Gastroenterology 2021 Mar 1. pii: S0016-5085(21)00459.
PMID: 33662385